EXAS vs SMBK · rev $2.76B vs P/E 16, rev $152.3M
EXACT Sciences Corporation (EXAS) versus SmartFinancial, Inc. (SMBK) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
SmartFinancial, Inc. (SMBK) is a banks - regional company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SMBK revenue for 2026-06-30 was $152.3M. Net income was $30.0M. SMBK currently screens at market cap $614.0M and trailing P/E 16.0.
EXAS currently screens at market cap $20.03B. SMBK currently screens at market cap $614.0M and trailing P/E 16.0.
Not investment advice. Open the EXAS and SMBK stock pages for the full models.
Not investment advice.